关注
Marwan Sheikh-Taha
Marwan Sheikh-Taha
在 lau.edu.lb 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients
FH Mourad, AV Hoffbrand, M Sheikh‐Taha, S Koussa, AI Khoriaty, ...
British journal of haematology 121 (1), 187-189, 2003
2032003
Comparison between deferoxamine and deferiprone (L1) in iron‐loaded thalassemia patients
A Taher, M Sheikh‐Taha, S Koussa, A Inati, R Neeman, F Mourad
European Journal of Haematology 67 (1), 30-34, 2001
992001
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
M Sheikh-Taha, M Asmar
BMC geriatrics 21, 1-6, 2021
852021
Efficacy and tolerability of peginterferon alpha‐2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection
A Inati, A Taher, S Ghorra, S Koussa, M Taha, E Aoun, AI Sharara
British journal of haematology 130 (4), 644-646, 2005
802005
Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA
M Sheikh-Taha, H Dimassi
BMC Cardiovascular Disorders 17, 1-6, 2017
582017
Treatment of apixaban-and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate
M Sheikh-Taha
Internal and Emergency Medicine 14, 265-269, 2019
472019
Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis
M Sheikh-Taha, LC Corman
Multiple Sclerosis Journal 23 (6), 872-874, 2017
442017
Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease
A Inati, KM Musallam, JC Wood, M Sheikh‐Taha, L Daou, AT Taher
European journal of haematology 83 (6), 565-571, 2009
442009
Safety and effectiveness of 100 mg/kg/day deferiprone in patients with thalassemia major: a two-year study
A Taher, M Sheikh-Taha, A Sharara, A Inati, S Koussa, G Ellis, AP Dhillon, ...
Acta haematologica 114 (3), 146-149, 2005
402005
Use of acid suppressive therapy in hospitalized non-critically ill patients
M Sheikh-Taha, S Alaeddine, J Nassif
World Journal of Gastrointestinal Pharmacology and Therapeutics 3 (6), 93, 2012
352012
Effect of age and sex on warfarin dosing
G Khoury, M Sheikh-Taha
Clinical pharmacology: advances and applications, 103-106, 2014
332014
Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study
WH Ramadan, GM El Khoury, ME Deeb, M Sheikh-Taha
Neuropsychiatric Disease and Treatment, 2299-2305, 2016
252016
Idarucizumab for reversal of dabigatran: single-center real-world experience
M Sheikh-Taha
American Journal of Cardiovascular Drugs 19, 59-64, 2019
222019
Possible montelukast-induced angioedema
R Sabbagh, M Sheikh-Taha
American Journal of Health-System Pharmacy 66 (19), 1705-1706, 2009
152009
Reversal of apixaban and rivaroxaban using activated prothrombin complex concentrates in patients with major bleeding
M Sheikh-Taha, RM Crawley
American Journal of Cardiovascular Drugs 20, 295-299, 2020
122020
Evaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals
M Sheikh-Taha, Z Hijazi
Springerplus 3, 1-6, 2014
122014
Oral aphthous ulcers associated with orlistat
M Sheikh-Taha, S Ghosn, A Zeitoun
American Journal of Health-System Pharmacy 69 (17), 1462-1464, 2012
112012
Hydroxyurea use in lebanese patients with β-thalassemia intermedia
A Taher, M Sheikh-Taha
Journal of Pediatric Hematology/Oncology 28 (2), 107, 2006
112006
Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA
M Sheikh-Taha, H Dimassi
BMC geriatrics 18, 1-6, 2018
92018
Use of deep vein thrombosis prophylaxis in hospitalized cancer patients
Z Awar, M Sheikh-Taha
Blood coagulation & fibrinolysis 20 (7), 571-574, 2009
82009
系统目前无法执行此操作,请稍后再试。
文章 1–20